PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 5339.27M
Enterprise Value 3315.27M
Trailing P/E N/A
Forward P/E 169.60
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2,607.13
Price/Book (mrq)7.07
Enterprise Value/Revenue 32,422.76
Enterprise Value/EBITDA 6-12.53

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-64.65%
S&P500 52-Week Change 324.65%
52 Week High 311.0900
52 Week Low 32.5100
50-Day Moving Average 33.1263
200-Day Moving Average 34.0784

Share Statistics

Avg Vol (3 month) 3124.76k
Avg Vol (10 day) 3113.68k
Shares Outstanding 597.49M
Float 78.49M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Jan. 14, 2020) 42.62M
Short Ratio (Jan. 14, 2020) 424.45
Short % of Float (Jan. 14, 2020) 4N/A
Short % of Shares Outstanding (Jan. 14, 2020) 42.56%
Shares Short (prior month Dec. 12, 2019) 42.71M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Jan. 17, 2019

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-20,512.69%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)130.13k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-36.64k
EBITDA -25.15M
Net Income Avi to Common (ttm)-31.22M
Diluted EPS (ttm)-0.3410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.8M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)1.38M
Total Debt/Equity (mrq)2.87
Current Ratio (mrq)5.21
Book Value Per Share (mrq)0.49

Cash Flow Statement

Operating Cash Flow (ttm)-26.84M
Levered Free Cash Flow (ttm)N/A